A Brief Case Management Intervention to Promote Personal Recovery and Prevent Psychiatric Involuntary Readmissions.

NCT07497763 | Not Yet Recruiting DMC

• 2 other identifiers: 2026-0025010.005.859
• Study Type: interventional
• Target: 262
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this randomized control trial is to assess the effectiveness of a Brief Case Management (BCM) intervention aimed at promoting personal recovery and reducing the negative effects of coercion among people involuntarily admitted to a psychiatric hospital. The main questions it aims to answer are :

• Does the Brief Case Management intervention reduce the incidence of involuntary readmission18 months after the initial involuntary hospitalisation?
• What impact does the Brief Case Management intervention have on patients' involuntary readmission 6 months after the initial involuntary hospitalisation, as well as on their personal recovery, perceived coercion, satisfaction with treatment, and on their exposure to other forms of formal and informal coercion? Participants will be randomly assigned to either the control or the intervention group, accordingly they will be asked to take part in: Control Group:
• Three evaluation sessions (baseline, 6 and 18 months follow-up); Intervention Group :
• Three evaluation sessions (baseline, 6 and 18 months follow-up);
• The 5 sessions of the brief case management intervention (6th session optional).

Conditions

Psychiatric Disorder; Involuntary Psychiatric Hospitalization

Keywords

coercion; involuntary admission; personal recovery; case management; psychiatry

Outcome Measures

Primary Outcomes (1)

• Number of involuntary readmission(s) (long-term)

  The study's primary outcome will be the number of involuntary readmissions occurred at any hospital of the Canton of Vaud 18 months after study enrolment (T2). Data on involuntary readmissions will be extracted from the Register of Protection Measures (RMP) of the Canton of Vaud and the participants medical records.

  Assessed at 18-month follow-up (T2).

Secondary Outcomes (18)

• Number of involuntary readmission(s) (short-term)

  Assessed at 6-month follow-up (T1).

• Recovery Assessment Scale (RAS)

  3 time point assessment: at baseline (T0), 6-month follow-up (T1), 18-month follow-up (T2).

• Empowerment Scale

  3 time point assessment: at baseline (T0), 6-month follow-up (T1) and 18-month follow-up (T2).

• Rosenberg Self-Esteem Scale (RSS)

  3 time point assessment : at baseline (T0), 6-month follow-up (T1), 18-month follow-up (T2).

• Paradox of Self-Stigma scale (PaSS-24)

  3 time point assessment : at baseline (T0), 6-month follow-up (T1) and 18-month follow-up (T2).

Study Arms (2)

Control Group

ACTIVE COMPARATOR

Treatment as usual (TAU): standard inpatient and outpatient psychiatric care

Other: TAU

Intervention Group

EXPERIMENTAL

Brief Case Management intervention

Other: Brief Case Management intervention

Interventions

Brief Case Management intervention OTHER

The BCM intervention aims to support patients during the difficult phase of involuntary hospitalisation and reduce the impact of this short-term event on their long-term recovery process. It is provided by a nurse or social worker case manager. Developed in collaboration with people who have experienced coercion, the intervention starts during the hospital stay, at the latest two weeks after admission, and lasts for a maximum of two months after discharge. The intervention consists of five sessions, the order of which may vary according to the specific needs of the patient: Session 1: Definition of "personal recovery" and impact of coercion on it Session 2 and 3: Elaboration of the Personal Recovery Plan (PRP) Session 4: Network meeting to discuss the PRP Session 5: Finalisation of the PRP For those who request it, an additional session can be arranged after three months to monitor progress and eventually adjust the recovery plan.

Intervention Group

TAU OTHER

Standard inpatient and outpatient psychiatric care.

Control Group

Eligibility Criteria

• Age: 18 Years - 64 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• To have been involuntarily admitted by a medical doctor;
• To be aged between 18 and 64 years;
• To domiciled in the Greater Lausanne area;

You may not qualify if:

• Patients with an organic mental disorder (F0, ICD-10);
• Patients with intellectual disability (F7, ICD-10);
• Patients unable to provide written consent due to a lack of discernment;
• Patients unable to speak French well enough to participate in the study without the help of an interpreter.

Sponsors & Collaborators

• Stéphane Morandi: lead
• University of Lausanne: collaborator

Study Sites (1)

Lausanne University Hospital

Lausanne, Canton of Vaud, 1003, Switzerland

Location

MeSH Terms

Conditions

Mental Disorders

Study Officials

• Stéphane Morandi

  Centre Hospitalier Universitaire Vaudois, CHUV

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Stephane Morandi

CONTACT

+41 21 3140050; stephane.morandi@chuv.ch

Benedetta Silva

CONTACT

+41 21 314 45 92; Benedetta.Silva@chuv.ch

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Deputy Head of the Community Psychiatry Service, PD & MER

Model Details: Monocentric single-blinded randomised controlled trial

Study Record Dates

• First Submitted: March 23, 2026
• First Posted: March 27, 2026
• Study Start: June 1, 2026
• Primary Completion (Estimated): November 1, 2029
• Study Completion (Estimated): November 1, 2029
• Last Updated: May 22, 2026

Record last verified: 2026-05

Locations

CH (1)